Skip to main content
Contact Us
Subscribe
E-Edition
66°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
2025 Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cabaletta Bio Inc
(NQ:
CABA
)
3.110
-0.185 (-5.61%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cabaletta Bio Inc
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 29, 2024
Via
Benzinga
US Stocks Likely To Open In The Green To End November On A High: Are Markets Set For A Santa Claus Rally In December? Analysts Decode
November 29, 2024
U.S. stock futures advanced on Friday after a day's break for Thanksgiving as investors look to end November on a high note.
Via
Benzinga
Caballeta Bio Shares Surge The Most In 23 Months In A Single Day As It Unveils Plan To Meet FDA By 2025 For Systemic Sclerosis Drug Trial
November 28, 2024
Via
Benzinga
Exposures
Product Safety
CABA Stock Earnings: Cabaletta Bio Misses EPS for Q2 2024
August 08, 2024
CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Recap: Cabaletta Bio Q4 Earnings
March 21, 2024
Via
Benzinga
Analyst Ratings for Cabaletta Bio
November 29, 2023
Via
Benzinga
Where Cabaletta Bio Stands With Analysts
November 10, 2023
Via
Benzinga
Cell Therapy Mostly Used For Blood Cancer Shows Efficacy In Autoimmune Diseases As Well, But There Are Challenges
July 19, 2024
CAR-T therapy, originally used for blood cancers, shows promising results in treating lupus, as evidenced by Janina Paech's remarkable remission. This breakthrough offers new hope for autoimmune...
Via
Benzinga
Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 21, 2024
Via
Benzinga
Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
June 21, 2024
Via
Benzinga
Cabaletta Bio: Q3 Earnings Insights
November 09, 2023
Via
Benzinga
7 Analysts Have This to Say About Cabaletta Bio
October 24, 2023
Via
Benzinga
The Latest Analyst Ratings for Cabaletta Bio
October 04, 2023
Via
Benzinga
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 18, 2024
Via
Benzinga
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Via
Benzinga
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 15, 2024
Via
Benzinga
CABA Stock Earnings: Cabaletta Bio Misses EPS for Q1 2024
May 15, 2024
CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
NEXTracker Posts Upbeat Earnings, Joins monday.com, Nu Holdings And Other Big Stocks Moving Higher On Wednesday
May 15, 2024
Via
Benzinga
CABA Stock Earnings: Cabaletta Bio Misses EPS for Q4 2023
March 21, 2024
CABA stock results show that Cabaletta Bio missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Cramer: This REIT Is 'A Little Too Dicey'; As For Marathon Digital, 'Own The Pure'
March 06, 2024
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended holding onto Regions Financial Corporation (NYSE: RF).
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 22, 2024
Via
Benzinga
Verint Reports Strong Earnings, Joins Semtech, Alphabet And Other Big Stocks Moving Higher On Thursday
December 07, 2023
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining more than 100 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Leslie's Posts Weak Earnings, Joins Las Vegas Sands, Verve Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
November 29, 2023
U.S. stock futures traded higher this morning, with the Dow Jones futures gaining around 100 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Crude Oil Surges 2%; Tharimmune Shares Plummet
November 28, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday. The Dow traded up 0.27% to 35,429.20 while the NASDAQ rose 0.12% to 14,258.32. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 28, 2023
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 28, 2023
Via
Benzinga
Cantor Fitzgerald Maintains Overweight Rating for Cabaletta Bio: Here's What You Need To Know
November 15, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 24, 2023
October 24, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2023
October 19, 2023
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.